QUIT for Smoking, Cigarette
Phase-Based Progress Estimates
Effectiveness
Safety
Smoking, Cigarette+11 More
QUIT - BehavioralEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial is testing a cognitive-behavioral-based intervention to help smokers living with HIV quit smoking by reducing anxiety and depression.
Eligible Conditions
- Smoking, Cigarette
- Anxiety
- Smoking
- Smoking, Cessation
- Nicotine Dependence
- Depression
- HIV
Treatment Effectiveness
Effectiveness Progress
Other trials for Smoking, Cigarette
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: Time frame: 6-Month Follow-Up (approximately 6-months post quit date)
Time frame: 1-Month Follow-Up (end of treatment/approximately 1-month post quit date)
Short-Term Point Prevalence Smoking Abstinence
Time frame: 6-Month Follow-Up (approximately 6-months post quit date)
Long-Term Point Prevalence Smoking Abstinence
Trial Safety
Safety Progress
Other trials for Smoking, Cigarette
Trial Design
3 Treatment Groups
Standard of Care
1 of 3
Time and Intensity-Match Control
1 of 3
QUIT Treatment for Smoking Cessation and Distress Tolerance
1 of 3
Active Control
Experimental Treatment
360 Total Participants · 3 Treatment Groups
Primary Treatment: QUIT · No Placebo Group · N/A
QUIT Treatment for Smoking Cessation and Distress Tolerance
Behavioral
Experimental Group · 1 Intervention: QUIT · Intervention Types: BehavioralStandard of CareNoIntervention Group · 1 Intervention: Standard of Care · Intervention Types:
Time and Intensity-Match Control
Behavioral
ActiveComparator Group · 1 Intervention: Time-Matched Control (TM) · Intervention Types: BehavioralTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: time frame: 6-month follow-up (approximately 6-months post quit date)
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,673 Previous Clinical Trials
30,828,296 Total Patients Enrolled
4 Trials studying Smoking, Cigarette
4,121 Patients Enrolled for Smoking, Cigarette
University of Texas at AustinOTHER
284 Previous Clinical Trials
65,939 Total Patients Enrolled
1 Trials studying Smoking, Cigarette
102 Patients Enrolled for Smoking, Cigarette
The Fenway InstituteOTHER
9 Previous Clinical Trials
1,897 Total Patients Enrolled
University of HoustonOTHER
123 Previous Clinical Trials
38,806 Total Patients Enrolled
2 Trials studying Smoking, Cigarette
210 Patients Enrolled for Smoking, Cigarette
Southern Methodist UniversityOTHER
33 Previous Clinical Trials
5,504 Total Patients Enrolled
Baylor College of MedicineOTHER
914 Previous Clinical Trials
5,981,679 Total Patients Enrolled
Jasper Smits, PhDPrincipal InvestigatorUniversity of Texas at Austin
4 Previous Clinical Trials
820 Total Patients Enrolled
Michael Zvolensky, PhDPrincipal InvestigatorUniversity of Houston
1 Previous Clinical Trials
150 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You are HIV-positive.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Who else is applying?
What state do they live in?
| Texas | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Thomas Street Health Center | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 89.5% |
| Did not meet criteria | 10.5% |
Why did patients apply to this trial?
- "Maybe in hopes to find a cure to my tobacco addiction."
What questions have other patients asked about this trial?
- "How long does the study take to complete?"
How many prior treatments have patients received?
| 0 | 100.0% |
References
- Garey, Lorra, Megan R. Wirtz, Allison K. Labbe, Michael J. Zvolensky, Jasper A.J. Smits, Thomas P. Giordano, David Rosenfield, et al.. 2021. “Evaluation of an Integrated Treatment to Address Smoking Cessation and Anxiety/depressive Symptoms Among People Living with HIV: Study Protocol for a Randomized Controlled Trial”. Contemporary Clinical Trials. Elsevier BV. doi:10.1016/j.cct.2021.106420.
- Conall O'Cleirigh 2019. "Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIV". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03904186.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments